<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03618914</url>
  </required_header>
  <id_info>
    <org_study_id>SMILE Study</org_study_id>
    <nct_id>NCT03618914</nct_id>
  </id_info>
  <brief_title>Anemia and Inflammation</brief_title>
  <official_title>Interactive Effects of Iron Status and Inflammation on Serum Hepcidin and Erythrocyte Iron Incorporation in Young Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Swiss Federal Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ibn Tofail University-CNESTEN</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Swiss Federal Institute of Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During inflammation hepcidin concentrations are increased, leading to a decrease in iron
      absorption. In iron deficiency anemia hepcidin is suppressed due to the activation of
      erythropoiesis. Whether inflammation or anemia has the stronger effect on hepcidin is
      uncertain.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 15, 2017</start_date>
  <completion_date type="Actual">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">March 29, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fractional and total iron absorption</measure>
    <time_frame>14 days after the second baseline test meal administration</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Fractional and total iron absorption</measure>
    <time_frame>14 days after the test meal administered 24 hours after vaccination</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum hepcidin</measure>
    <time_frame>up to 36 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Interleukin 6</measure>
    <time_frame>up to 36 hours</time_frame>
    <description>inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum ferritin</measure>
    <time_frame>up to 36 hours</time_frame>
    <description>Iron status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum transferrin</measure>
    <time_frame>up to 36 hours</time_frame>
    <description>Iron status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum CRP</measure>
    <time_frame>up to 36 hours</time_frame>
    <description>inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum AGP</measure>
    <time_frame>up to 36 hours</time_frame>
    <description>inflammation</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Iron Deficiency Anemia</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>Non-anemic women</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>anemic women</arm_group_label>
    <description>anemia due to iron deficiency</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Dultavax and Vaxigrip</intervention_name>
    <description>All the women got an influenza/DTP vaccine in order to induce acute inflammation</description>
    <arm_group_label>Non-anemic women</arm_group_label>
    <arm_group_label>anemic women</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum Samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Young women with or without iron-deficiency anemia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &lt;27.5kg/m2

          -  body weight &lt;70kg

          -  either non-anemic (Hb&gt;12.5g/dl) or anemic (Hb between 8-12 g/dl and ferritin &lt;15ng/ml)

        Exclusion Criteria:

          -  pregnant or lactating

          -  chronic disease

          -  smoking

          -  inflammation defined as CRP&lt;5mg/L; AGP&lt;1g/L
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ibn Tofail University-CNESTEN</name>
      <address>
        <city>Rabat</city>
        <country>Morocco</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Morocco</country>
  </location_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>July 23, 2018</study_first_submitted>
  <study_first_submitted_qc>August 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2018</study_first_posted>
  <last_update_submitted>August 20, 2018</last_update_submitted>
  <last_update_submitted_qc>August 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Swiss Federal Institute of Technology</investigator_affiliation>
    <investigator_full_name>Prof. Michael B. Zimmermann</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

